Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001179110-15-011444
Filing Date
2015-07-22
Accepted
2015-07-22 21:48:51
Documents
2
Period of Report
2015-07-22

Document Format Files

Seq Description Document Type Size
1 FORM 3 - edgar.html 3  
1 FORM 3 - edgar.xml 3 2879
2 ex24schmid.htm EX-24 5216
  Complete submission text file 0001179110-15-011444.txt   9470
Mailing Address 2940 N. HIGHWAY 360 SUITE 400 GRAND PRAIRIE TX 75050
Business Address 2940 N. HIGHWAY 360 SUITE 400 GRAND PRAIRIE TX 75050 972.408.1360
Neos Therapeutics, Inc. (Issuer) CIK: 0001467652 (see all company filings)

EIN.: 270395455 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121
Business Address
Schmid John P. (Reporting) CIK: 0001478916 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37508 | Film No.: 151001070